Trial intelligence / Profile preview

Giomer Bioactive Barrier Varnish vs Fluoride Varnish for White Spot Lesions

NCT05306691Phase 1Unknown

Sponsor
Cairo University
Start
May 2022
Primary completion
Aug 2022
Modality
Implantable Devices
01

Overview

Phase 1, randomised trial of giomer varnish in dental caries (2 arms), sponsored by Cairo University. Primary endpoint: Change in Remineralization efficacy at 3 months. Status: unknown.

02

Drugs

giomer varnish
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT05306691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05306691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call